Gland Pharma on Friday said its board has appointed Shyamakant Giri as chief executive officer with effect from Jan. 15, 2025. Giri is currently the President (India Business & Emerging Markets) of Amneal Pharmaceuticals, responsible for the commercial expansion and growth in India and Rest of the World markets.
ADVERTISEMENT
Srinivas Sadu will continue to be the executive chairman of the company and support its next phase of growth, Gland Pharma said.
ADVERTISEMENT
RECOMMENDED FOR YOU
Gland Pharma Q2 Review - Beat Due To Controlled Costs; Base Business Yet To Witness Revival: Motilal Oswal
Nov 05, 2024
Gland Pharma Q2 Results: Profit Falls 16%, Meets Estimates
Nov 04, 2024
 11_07_24 (1).jpg?rect=0%2C0%2C3500%2C1969&auto=format%2Ccompress&format=webp&w=75)
Festive Effect: GST Mop-Up Grows 9% To Rs 1.87 Lakh Crore In October
Nov 01, 2024
Mankind Pharma Completes Acquisition Of Bharat Serums For Rs 13,768 Crore
Oct 23, 2024
POPULAR
1
Q2 Results Live: Titan, Mazagon Dock, GAIL, SJVN, Mankind To Announce Earnings Today
2
India’s Shadow Lenders Retreat As Bad Loans Rise Amid Crackdown
3
Private Property Can Be Redistributed For Common Good But Not Without Caveats, Says Supreme Court
4
Stock Market Live: Nifty, Sensex Near Day's Lows As Infosys, Airtel, ITC Drag
5